Proposed sale of WA production facility
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Little Green Pharma Ltd. has announced a proposed sale of its production facility in Western Australia, which includes an indoor cultivation facility and a GMP-compliant production facility. The company has signed a contract with Lauana Pty Ltd for the sale and leaseback of the site, with plans to use the proceeds for expansion in Australia and Europe. The sale is subject to various conditions, including buyer due diligence and financing, with a target settlement date set for mid-March.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Little Green Pharma Ltd. on 6ix
Earlier from Little Green Pharma
- Quarterly Activities Report and Appendix 4C
- Transformational Merger of LGP and Cannatrek
- US Executive Order to reschedule cannabis
- Half Yearly Report and Accounts
- Appendix 4E and 2025 Annual Report
Later from Little Green Pharma
- Scheme Booklet Registered by ASIC
- Termination of proposed sale and leaseback transaction
- Supplementary Scheme Booklet
- Scheme Approved by Cannatrek Shareholders
- Scheme Update
Follow Little Green Pharma into a list and get an email when it puts out news.
Follow Little Green Pharma